Clinical Trial Update: SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial from Rutgers evaluating sequential gemcitabine and mitomycin for favorable high‑risk upper tract urothelial carcinoma, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma
• Urothelial Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Urinary Bladder Cancer, Upper Tract Urothelial Cancer | Phase 2 | Status: NOT_YET_RECRUITING